Research Information for Patients Services

Contact Us  |  Ask Dr. Berman   |  Links  |  Webmaster

INDEX

Our Research

Support Resources

Appointments

Ask Dr. Berman

 

 

 

Home | Patient Information 

INFORMATION FOR PATIENTS

This page is under development

http://www.nhlbi.nih.gov/health/dci/Diseases/sarc/sar_whatis.html

What is sarcoidosis?

Sarcoidosis is a systemic granulomatous disease of unknown etiology that primarily affects the lung, although multi-organ involvement frequently occurs. 

Sarcoidosis (sar"koi-do'sis) involves inflammation that produces tiny lumps of cells in various organs in your body. The lumps are called granulomas (gran"u-lo'mahs) because they look like grains of sugar or sand. They are very small and can be seen only with a microscope.

These tiny granulomas can grow and clump together, making many large and small groups of lumps. If many granulomas form in an organ, they can affect how the organ works. This can cause symptoms of sarcoidosis.

Sarcoidosis can occur in almost any part of your body, although it usually affects some organs more than others. It usually starts in one of two places:

  • Lungs
  • Lymph nodes, especially the lymph nodes in your chest cavity.

Sarcoidosis also often affects your:

  • Skin
  • Eyes
  • Liver.

Less often, sarcoidosis affects your:

  • Spleen
  • Brain
  • Nerves
  • Heart
  • Tear glands
  • Salivary glands
  • Bones and joints.

Rarely, sarcoidosis affects other organs, including your:

  • Thyroid gland
  • Breasts
  • Kidneys
  • Reproductive organs.

Sarcoidosis almost always occurs in more than one organ at a time.

Sarcoidosis has an active and a nonactive phase:

  • In the active phase, the granulomas form and grow. In this phase, symptoms can develop, and scar tissue can form in the organs where the granulomas occur.
  • In the nonactive phase, the inflammation goes down, and the granulomas stay the same size or shrink. But the scars may remain and cause symptoms.

The course of the disease varies greatly among people.

  • In many people, sarcoidosis is mild. The inflammation that causes the granulomas may get better on its own. The granulomas may stop growing or shrink. Symptoms may go away within a few years.
  • In some people, the inflammation remains but doesn't get worse. You may also have symptoms or flare-ups and need treatment every now and then.
  • In other people, sarcoidosis slowly gets worse over the years and can cause permanent organ damage. Although treatment can help, sarcoidosis may leave scar tissue in the lungs, skin, eyes, or other organs. The scar tissue can affect how the organs work. Treatment usually does not affect scar tissue.

Changes in sarcoidosis usually occur slowly (e.g., over months). Sarcoidosis does not usually cause sudden illness. However, some symptoms may occur suddenly. They include:

  • Disturbed heart rhythms
  • Arthritis in the ankles
  • Eye symptoms.

In some serious cases in which vital organs are affected, sarcoidosis can result in death.

Sarcoidosis is not a form of cancer.

There is no known way to prevent sarcoidosis.

Sarcoidosis was once thought to be an uncommon condition. It's now known to affect tens of thousands of people throughout the United States. Because many people who have sarcoidosis have no symptoms, it's hard to know how many people have the condition.

Sarcoidosis was identified in the late 1860s. Since then, scientists have developed better tests to diagnose it and made advances in treating it.

 

 

What is inflammation?

 

 

Autoimmunity and sarcoidosis

 

 

 

Signs and symptoms of sarcoidosis

 

 

Causes of sarcoidosis

What Causes Sarcoidosis?

The cause of sarcoidosis is not known. And, there may be more than one thing that causes it.

Scientists think that sarcoidosis develops when your immune system responds to something in the environment (e.g., bacteria, viruses, dust, chemicals) or perhaps to your own body tissue (autoimmunity).

Normally, your immune system defends your body against things that it sees as foreign and harmful. It does this by sending special cells to the organs that are being affected by these things. These cells release chemicals that produce inflammation around the foreign substance or substances to isolate and destroy them.

In sarcoidosis, this inflammation remains and leads to the development of granulomas or lumps.

Scientists have not yet identified the specific substance or substances that trigger the immune system response in the first place. They also think that sarcoidosis develops only if you have inherited a certain combination of genes.

You can't catch sarcoidosis from someone who has it.

More research is needed to discover what causes sarcoidosis

The etiology remains unclear; however, environmental, genetic, ethnic, and familial factors probably modify expression of the disease. As an example, African Americans are at greater risk of mortality and morbidity than are white Americans, and more often have a family history of sarcoidosis.

Sarcoidosis, first described 125 years ago,  It is likely that expression of the disorder in response to one or more inciting agents is modified by the genetics of the host immune response.

In addition, an infectious component has long been suspected. Although many clinical features and associated syndromes have been described, the phenotype of sarcoidosis at diagnosis provides only limited information about the etiology or pathogenesis of the disorder.

Getting a diagnosis

 

Treatment

Most patients with sarcoidosis recover spontaneously, but some develop chronic, debilitating disease.  Corticosteroids and other drugs, although effective at controlling disease activity, may not influence the overall course of disease.

Immunomodulatory Therapy

Biologic Response Modifiers

Treatment duration

Prognosis

Spontaneous remission or disease stabilization is reported to occur in approximately two-thirds of cases, but many patients have chronic progressive disease.

  • About 4–7% of patients have serious extrapulmonary (i.e., heart, central nervous, liver, or eye) involvement at the time of presentation; this possibility increases as the disease progresses.

  • Data on persistent disease and relapses from centers in the United States that treat a large number of patients with sarcoidosis vary from 20% in Iowa (4) to more than 50% among patients in Philadelphia whose treatment was stopped.

  • Mortality rates at referral centers are high at 3–10%, whereas low mortality is reported from nonreferral centers.

  • No good test for predicting disease progression exists and better means are needed to differentiate between remitting and chronic sarcoidosis.

Finding a specialist

 

 

Support and coping

 

 

 

Research

Because of the many uncertainties about the pathogenesis, course, and management of sarcoidosis, the National Heart, Lung, and Blood Institute convened a working group to identify future research directions and opportunities for sarcoidosis. These include developing a tissue bank, using novel methods to identify genetic factors, studying the immunopathogenesis with human tissue and animal models, exploring new approaches to diagnose and manage disease, and, finally, conducting randomized controlled trials to assess new therapies.

Frequently asked questions

 

Source material:  http://www.nhlbi.nih.gov/meetings/workshops/sarcoid-wkgp.htm

 

Glossary of terms

News and Events

News 1
  News 2  
  News 3  
  News 4